Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dycom Industries (DY) Common Equity (2016 - 2025)

Dycom Industries' Common Equity history spans 16 years, with the latest figure at $1.5 billion for Q4 2025.

  • On a quarterly basis, Common Equity rose 20.23% to $1.5 billion in Q4 2025 year-over-year; TTM through Oct 2025 was $1.5 billion, a 20.23% increase, with the full-year FY2025 number at $1.2 billion, up 17.49% from a year prior.
  • Common Equity hit $1.5 billion in Q4 2025 for Dycom Industries, up from $1.4 billion in the prior quarter.
  • Over the last five years, Common Equity for DY hit a ceiling of $1.5 billion in Q4 2025 and a floor of $758.3 million in Q2 2022.
  • Historically, Common Equity has averaged $1.0 billion across 5 years, with a median of $930.7 million in 2023.
  • Biggest five-year swings in Common Equity: dropped 11.21% in 2021 and later grew 22.75% in 2023.
  • Tracing DY's Common Equity over 5 years: stood at $810.8 million in 2021, then grew by 5.9% to $858.6 million in 2022, then increased by 22.75% to $1.1 billion in 2023, then increased by 17.05% to $1.2 billion in 2024, then grew by 20.23% to $1.5 billion in 2025.
  • Business Quant data shows Common Equity for DY at $1.5 billion in Q4 2025, $1.4 billion in Q3 2025, and $1.3 billion in Q2 2025.